Search research articles
Contact Us
Filters
Showing results (91-100 of 117) with videos related to
Page
of 12
Sort By:
Cancer Management and Research
|
September 14, 2020
A Novel Epitope Quality-Based Immune Escape Mechanism Reveals Patient's Suitability for Immune Checkpoint Inhibition
Michael Wessolly, Susann Stephan-Falkenau, Anna Streubel, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 17, 2025
Physical activity and <i>APOE</i> neuropathology score modify the association of age and [<sup>11</sup>C]-PiB-PET amyloid burden in a cohort enriched with risk for Alzheimer's disease
Eli G Blum, Kyle J Edmunds, Brianne Breidenbach, et al.
Nature Reviews. Clinical Oncology
|
February 23, 2026
Innovative approaches for lung cancer screening and interception
Jianjun Zhang, Matthew D Park, Tej Pandya, et al.
ERJ Open Research
|
February 3, 2021
The DIAMORFOSIS (DIAgnosis and Management Of lung canceR and FibrOSIS) survey: international survey and call for consensus
Argyris Tzouvelekis, Katerina Antoniou, Michael Kreuter, et al.
The European Respiratory Journal
|
May 18, 2023
Developing a pan-European technical standard for a comprehensive high-quality lung cancer computed tomography screening programme: an ERS technical standard
David R Baldwin, Emma L O'Dowd, Ilona Tietzova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 22, 2020
Entospletinib in Combination with Induction Chemotherapy in Previously Untreated Acute Myeloid Leukemia: Response and Predictive Significance of <i>HOXA9</i> and <i>MEIS1</i> Expression
Alison R Walker, John C Byrd, James S Blachly, et al.
Blood Advances
|
October 17, 2017
A phase 2 study incorporating sorafenib into the chemotherapy for older adults with <i>FLT3</i>-mutated acute myeloid leukemia: CALGB 11001
Geoffrey L Uy, Sumithra J Mandrekar, Kristina Laumann, et al.
Journal of Hematology & Oncology
|
January 17, 2025
Olutasidenib in combination with azacitidine induces durable complete remissions in patients with relapsed or refractory mIDH1 acute myeloid leukemia: a multicohort open-label phase 1/2 trial
Jorge E Cortes, Gail J Roboz, Maria R Baer, et al.
Leukemia
|
January 13, 2025
Prognostic, biological, and structural implications of FLT3-JMD point mutations in acute myeloid leukemia: an analysis of Alliance studies
Nadeen Anabtawi, Deedra Nicolet, Najla Alotaibi, et al.
Leukemia
|
February 24, 2023
Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study
Krzysztof Mrózek, Jessica Kohlschmidt, James S Blachly, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 117) with videos related to
Sort By:
Page
of 12
Cancer Management and Research
|
September 14, 2020
A Novel Epitope Quality-Based Immune Escape Mechanism Reveals Patient's Suitability for Immune Checkpoint Inhibition
Michael Wessolly, Susann Stephan-Falkenau, Anna Streubel, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 17, 2025
Physical activity and <i>APOE</i> neuropathology score modify the association of age and [<sup>11</sup>C]-PiB-PET amyloid burden in a cohort enriched with risk for Alzheimer's disease
Eli G Blum, Kyle J Edmunds, Brianne Breidenbach, et al.
Nature Reviews. Clinical Oncology
|
February 23, 2026
Innovative approaches for lung cancer screening and interception
Jianjun Zhang, Matthew D Park, Tej Pandya, et al.
ERJ Open Research
|
February 3, 2021
The DIAMORFOSIS (DIAgnosis and Management Of lung canceR and FibrOSIS) survey: international survey and call for consensus
Argyris Tzouvelekis, Katerina Antoniou, Michael Kreuter, et al.
The European Respiratory Journal
|
May 18, 2023
Developing a pan-European technical standard for a comprehensive high-quality lung cancer computed tomography screening programme: an ERS technical standard
David R Baldwin, Emma L O'Dowd, Ilona Tietzova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 22, 2020
Entospletinib in Combination with Induction Chemotherapy in Previously Untreated Acute Myeloid Leukemia: Response and Predictive Significance of <i>HOXA9</i> and <i>MEIS1</i> Expression
Alison R Walker, John C Byrd, James S Blachly, et al.
Blood Advances
|
October 17, 2017
A phase 2 study incorporating sorafenib into the chemotherapy for older adults with <i>FLT3</i>-mutated acute myeloid leukemia: CALGB 11001
Geoffrey L Uy, Sumithra J Mandrekar, Kristina Laumann, et al.
Journal of Hematology & Oncology
|
January 17, 2025
Olutasidenib in combination with azacitidine induces durable complete remissions in patients with relapsed or refractory mIDH1 acute myeloid leukemia: a multicohort open-label phase 1/2 trial
Jorge E Cortes, Gail J Roboz, Maria R Baer, et al.
Leukemia
|
January 13, 2025
Prognostic, biological, and structural implications of FLT3-JMD point mutations in acute myeloid leukemia: an analysis of Alliance studies
Nadeen Anabtawi, Deedra Nicolet, Najla Alotaibi, et al.
Leukemia
|
February 24, 2023
Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study
Krzysztof Mrózek, Jessica Kohlschmidt, James S Blachly, et al.
Page
of 12